Thursday, July 11, 2019

Philbro’s working on an ASF vaccine

Phibro Animal Health Corporation of New Jersey said it will seek patents for its early-stages research to develop a vaccine against African Swine Fever.

It’s approach involves the identification of immunogenic epitopes and proteins that show strong potential to form the basis for a vaccine against the devastating disease that has wiped out about half of China’s pigs and about a quarter of those in Viet Nam.

Phibro said it hopes to create a specific epitope-based vaccine rather than following the more conventional path of an attenuated live vaccine. 

If successful, Phibro said this approach would not only be effective, but also safer than a live vaccine which might spread the disease.